The US FDA has extended its approval of the Deep Transcranial Magnetic Stimulation system from Israel’s BrainsWay (see here previously). It can now be used to treat depression up to the patient’s 86th birthday. The previous maximum age limit was 67.
Treating late life depression
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.